These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3613167)

  • 1. [Studies on the determination of heparin cofactor II (HC II) activity using a synthetic chromogenic substrate].
    Ohtsubo M; Asai M; Asai K; Takagi A
    Rinsho Byori; 1987 May; 35(5):565-70. PubMed ID: 3613167
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory determination of heparin cofactor II.
    Ezenagu LC; Brandt JT
    Arch Pathol Lab Med; 1986 Dec; 110(12):1149-51. PubMed ID: 3778142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Constitutional dysfunction of heparin cofactor II with a tendency for venous thrombosis].
    Marbet GA; Zbinden B; Duckert F
    Schweiz Med Wochenschr; 1988 Oct; 118(43):1586-8. PubMed ID: 3238395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of heparin cofactor II by heparin and dermatan sulfate.
    Tollefsen DM
    Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The second cofactor of heparin].
    Sie P
    Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation.
    Andersson TR
    Thromb Res; 1987 Apr; 46(2):355-62. PubMed ID: 3603428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turnover study of heparin cofactor II in healthy man.
    Sié P; Dupouy D; Pichon J; Boneu B
    Thromb Haemost; 1985 Oct; 54(3):635-8. PubMed ID: 3841420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immuno turbidimetric assay of heparin cofactor II].
    Takahashi K; Yamagishi R; Sakuragawa N; Shimamoto M; Ohsawa T; Kita M
    Rinsho Byori; 1988 Aug; 36(8):947-51. PubMed ID: 3241422
    [No Abstract]   [Full Text] [Related]  

  • 10. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P; Jacquot C; Capron L; Frydman MO; Vignon D; Aiach M
    Thromb Haemost; 1987 Jun; 57(3):263-8. PubMed ID: 3660328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of heparin cofactor II is not regulated by inflammatory cytokines in human hepatoma cells: comparison with plasminogen activator inhibitor type-1.
    Koike C; Hayakawa Y; Niiya K; Sakuragawa N; Sasaki H
    Thromb Haemost; 1996 Feb; 75(2):298-302. PubMed ID: 8815580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombin activity and disaccharide composition of dermatan sulfate from different bovine tissues.
    Osborne SA; Daniel RA; Desilva K; Seymour RB
    Glycobiology; 2008 Mar; 18(3):225-34. PubMed ID: 18156656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin cofactor II, a thrombin inhibitor with a still not clarified physiologic role].
    Rossi EB; Duboscq CL; Kordich LC
    Medicina (B Aires); 1999; 59(1):95-104. PubMed ID: 10349131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis.
    Lopaciuk S; Bykowska K; Kopeć M
    Pol J Pharmacol; 1996; 48(1):109-11. PubMed ID: 9112638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin cofactor II activity in plasma: application of an automated assay method to the study of a normal adult population.
    Andersson TR; Larsen ML; Handeland GF; Abildgaard U
    Scand J Haematol; 1986 Jan; 36(1):96-102. PubMed ID: 3754062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Juvenile cerebral infarction associated with heparin cofactor II abnormality. A case report].
    Hamasaki S; Motomura M; Nakane S; Nishiura Y; Kondo S
    Rinsho Shinkeigaku; 2000 Apr; 40(4):402-4. PubMed ID: 10967662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heparin cofactor II].
    Sie P
    Rev Prat; 1990 Apr; 40(11):1030-1. PubMed ID: 2343242
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin cofactor II modulates the response to vascular injury.
    Tollefsen DM
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):454-60. PubMed ID: 17194895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of dermatan sulfate active site for heparin cofactor II by 1H nuclear magnetic resonance spectroscopy.
    Mascellani G; Liverani L; Prete A; Bergonzini G; Bianchini P; Torri G; Bisio A; Guerrini M; Casu B
    Anal Biochem; 1994 Nov; 223(1):135-41. PubMed ID: 7695089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.